IIT Madras startup develops smart devices to prevent COVID-19 spread via trash

The product ‘AirBin’ is aimed at remotely monitoring waste levels and generates alerts for expeditious disposal through a smartphone application and can be retrofitted into existing bins as well

Moneycontrol News

April 27, 2020 / 03:40 PM IST

An Indian Institute of Technology (IIT), Madras incubated startup --Antariksh Waste Ventures -- has developed an Internet of Things (IoT) enabled ‘smart bin’ to prevent spread of novel coronavirus, or COVID-19, through trash disposal containers.

The product ‘AirBin’ is aimed at remotely monitoring waste levels and generates alerts for expeditious disposal through smartphone applications and can be retrofitted into existing bins as well. The company said in a statement that AirBin would be useful at contagion vulnerable points (CVPs) like hospitals, clinics, public bins and quarantine zones.

The objective is to help rural and urban local bodies clear every bin before it overflows and to accelerate sustainability. The company said the product is on track to hit the market in around five months. The cost details have not yet been shared.

AirBin

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show